Further assessments using the UALCAN database indicated that the elevated DNA methylation levels of EZH2 in the promoter region of HCC tissues compared with normal liver tissues were statistically significant (p < 0.01) (Fig. 5e). The gene discussed is EZH2; the disease is hepatocellular carcinoma.